Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients

BACKGROUND: Non-small cell lung cancer (NSCLC) is a major cause of cancer-related death worldwide due to poor patient prognosis and clinical outcome. Here, we studied the genetic variations underlying NSCLC pathogenesis based on their association to patient outcome after gemcitabine therapy. RESULTS...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Genomics
Glavni autori: Mah, Tzia Liang, Yap, Xin Ning Adeline, Limviphuvadh, Vachiranee, Li, Nanpu, Sridharan, Srinath, Kuralmani, Vellaisemy, Feng, Mengling, Liem, Natalia, Adhikari, Sharmila, Yong, Wei Peng, Soo, Ross A, Maurer-Stroh, Sebastian, Eisenhaber, Frank, Tong, Joo Chuan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4290611/
https://ncbi.nlm.nih.gov/pubmed/25521664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2164-15-S9-S20
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items